Suppr超能文献

一项关于使用附着银浸渍袖套预防中心静脉导管相关感染的前瞻性随机对照研究。

A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection.

作者信息

Smith H O, DeVictoria C L, Garfinkel D, Anderson P, Goldberg G L, Soeiro R, Elia G, Runowicz C D

机构信息

Department of Obstetrics and Gynecology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10467, USA.

出版信息

Gynecol Oncol. 1995 Jul;58(1):92-100. doi: 10.1006/gyno.1995.1189.

Abstract

The VitaCuff catheter, a specialized central venous catheter (CVC) with an attached silver-impregnated cuff, is designed to permit percutaneous placement and prolonged venous access. A prospective randomized study was undertaken comparing the VitaCuff with standard triple lumen catheters to determine if the VitaCuff reduces infection during extended use. All consenting patients underwent percutaneous placement of subclavian lines. By study design, control and VitaCuff catheters could remain in site for up to 7 and 14 days, respectively. Cultures were obtained from the preinsertion skin site, and upon removal, from the skin, hubs, infusates, CVC tip, and cuff. Statistical methods included chi 2, the Student t test, and the log-rank test on Kaplan-Meier estimates. Of 133 patients completing this study, 64 patients (48.1%) underwent VitaCuff placement and 69 patients (51.8%) served as controls. In 124 patients (93.2%), the indication for catheter placement was for perioperative care. Overall, 67 patients (50.4%) required central venous access > 7 days, necessitating > or = 1 additional line in 29 patients (21.8%). The incidence of pneumothorax per patient from the initial central line insertion was 4/104 (3.85%), significantly lower than the 4/29 (13.8%) incidence during secondary catheter placement (P = 0.046). Culture results upon catheter removal demonstrated a reduction in colonization of skin sites and hubs for the VitaCuff patients, but not for catheter tips or infusates. Regardless of the type of catheter used, colonization was dependent upon duration of insertion. The incidence of catheter-related sepsis was 6.8%, and did not differ significantly between the study groups. Multiple CVC insertions increase the incidence of pneumothorax. Because VitaCuff catheters permit extended access up to 14 days without increasing the incidence of sepsis, we recommend their use in patients who require prolonged CVC access.

摘要

VitaCuff导管是一种特殊的中心静脉导管(CVC),带有一个浸渍银的袖套,旨在允许经皮放置并延长静脉通路。进行了一项前瞻性随机研究,将VitaCuff导管与标准三腔导管进行比较,以确定VitaCuff导管在长期使用期间是否能减少感染。所有同意参与的患者均接受了锁骨下静脉置管的经皮操作。根据研究设计,对照导管和VitaCuff导管分别可在体内保留长达7天和14天。在置管前从皮肤部位获取培养样本,并在拔除导管时从皮肤、接头、输注液、CVC尖端和袖套获取培养样本。统计方法包括卡方检验、学生t检验以及对Kaplan-Meier估计值进行对数秩检验。在完成本研究的133例患者中,64例患者(48.1%)接受了VitaCuff导管置管,69例患者(51.8%)作为对照。在124例患者(93.2%)中,置管的指征是围手术期护理。总体而言,67例患者(50.4%)需要中心静脉通路超过7天,其中29例患者(21.8%)需要额外置管≥1根。初次中心静脉置管时每位患者气胸的发生率为4/104(3.85%),显著低于二次置管时4/29(13.8%)的发生率(P = 0.046)。导管拔除时的培养结果显示,VitaCuff导管组患者皮肤部位和接头的定植减少,但导管尖端或输注液未减少。无论使用何种类型的导管,定植都取决于置管时间。导管相关败血症的发生率为6.8%,研究组之间无显著差异。多次进行CVC置管会增加气胸的发生率。由于VitaCuff导管可允许长达14天的延长通路且不增加败血症的发生率,我们建议在需要长期CVC通路的患者中使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验